Stem-cell therapy is one of the most promising medical innovations of the 21st century — helping patients recover from chronic diseases, injuries, and age-related decline.
However, like any medical treatment, stem-cell therapy has potential side effects if performed incorrectly or without clinical oversight.

At EDNA Wellness, we believe that informed patients make safer choices. All our Umbilical-Cord-Derived Mesenchymal Stem Cells (UC-MSCs)are processed in TISTR certified GMP facilities to guarantee quality, purity, and patient safety.

Understanding Stem-Cell Therapy and Its Safety

Stem-cell therapy involves infusing or injecting living cells capable of repairing damaged tissues or modulating inflammation. While research shows high safety in clinical settings, risks increase significantly when treatments are unregulated or improperly performed

EDNA Wellness follows international guidelines — including Thai FDA, WHO, and ISSCR (International Society for Stem Cell Research) — to ensure evidence-based care.

Common Mild Side Effects

Even under proper medical care, patients may experience short-term effects as their body adjusts to the infusion.

1. Fatigue or drowsiness – due to metabolic activity after infusion.
2. Headache or light pressure – common after intrathecal (spinal) delivery; resolves in 24–48 hours.
3. Mild fever or chills – transient immune response to new cells.
4. Injection-site soreness or redness – typical with local injections.
5. Temporary muscle ache – mild inflammation as tissue repair begins.

These symptoms usually resolve naturally and are signs of the body’s biological response, not rejection.

Less Common Side Effects

When not closely monitored, or when performed in non-certified clinics, more significant issues may arise:

1. Infection risk – if cells or tools are not sterile.
2. Allergic reaction – from untested serum or storage medium.
3. Blood clotting (thrombosis) – very rare; minimized by correct infusion rate.
4. Spinal headache – due to CSF pressure change after intrathecal therapy; prevented by medical technique and rest.

EDNA Wellness strictly prevents these complications through GMP lab control, patient screening, and sterile technique.

Severe Risks (Extremely Rare)

Globally, a few incidents have been reported — mostly from unregulated providers. These include:

• Tumor formation – from non-MSC or embryonic stem-cell misuse.
• Immune reaction – from incompatible or contaminated cell lines.
• Organ embolism – from improper IV infusion speed or non-filtered cells.

Such risks are virtually nonexistent with UC-MSCs when sourced from GMP laboratories, where cells are screened for viability, sterility, and endotoxin levels before every use.

The Importance of GMP Certification

GMP (Good Manufacturing Practice) ensures cells are processed in sterile, traceable environments with rigorous quality control.

At EDNA Wellness, every UC-MSC batch:

• Comes from ethically donated umbilical cords after healthy births.
• Undergoes sterility, viability, mycoplasma, and endotoxin testing.
• Includes batch number, certificate of analysis, and TISTRverification.
• Is stored and transported in temperature-controlled conditions.

This system minimizes biological risk and ensures clinical consistency.

Factors That Influence Side Effects

Factor	Influence on Risk	EDNA Wellness Mitigation
Cell source	Poor-quality or untested cells can cause reaction	Use of GMP-certified UC-MSCs only
Dosage	Excessive cell count may trigger inflammation	Follow published safe ranges (1–2 × 10⁷ cells/session)
Route of administration	Spinal or intra-articular routes carry procedural risk	Performed by qualified physicians only
Patient condition	Diabetes, infection, or immune disease may raise complication risk	Full pre-treatment medical screening
Facility hygiene	Non-sterile conditions risk infection	ISO-class cleanroom environments

Signs to Monitor After Treatment

Patients should report immediately if they experience:

• Persistent fever (>38°C for more than 2 days)
• Severe headache or dizziness
• Breathing difficulty
• Local swelling or discharge at injection site

EDNA Wellness provides 24-hour patient support and follow-up appointments to ensure safe recovery.

Why Certified Clinics Matter

Unfortunately, some unregulated clinics in Asia have marketed “miracle” stem-cell treatments without transparent protocols or real physicians. These often involve:

• Low cell counts (e.g., 3 million cells mislabeled as high-dose).
• Mixing steroids or vitamins to simulate fast results.
• Lack of lab certification or physician license.

Such practices not only reduce effectiveness but also endanger patient safety.
EDNA Wellnessupholds strict ethics, authenticity, and medical supervision to eliminate these risks.

Global Safety Data (2020–2025)

A global review covering >1,200 MSC-treated patients reported:

• Serious adverse event rate < 1 %.
• No confirmed cases of tumor or genetic mutation.
• Most reactions mild and transient (Wang et al., 2024).

This confirms the excellent safety profile of properly administered UC-MSC therapy when performed under medical supervision.

Stem-cell therapy is remarkably safe when performed in a certified medical environment with GMP-grade materials. However, as demand grows, patient education and clinic verification become essential. At EDNA Wellness, every UC-MSC treatment follows international safety standards — from donor screening to infusion — ensuring patients receive authentic, monitored regenerative care.

About EDNA Wellness

EDNA Wellness is a private clinic specializing in Stem Cell Therapy in Bangkok, Thailand for Neurology & Stroke as well as Bones & Joints. Beyond rehabilitation, we also provide aesthetic and wellness treatments to support your full-body vitality. All delivered with expert care and compassion

For more information or inquiries, contact us via

LINE @ednawellness

WhatsApp +66 (0) 64 505 5599

www.ednawellness.com

References

• Kim, H. J., Park, Y. M., & Choi, Y. (2023). Safety of umbilical-cord-derived mesenchymal stem cells in regenerative therapies: A comprehensive review. Stem Cell Research & Therapy, 14(5), 452–466.*
• Moll, G., Rasmusson-Duprez, I., & Ringdén, O. (2023). Mesenchymal stromal cell therapy: From laboratory to clinical practice—Safety lessons learned. Cell Stem Cell, 30(1), 12–25.*
• Wang, L., Zhao, Y., & Xu, Q. (2024). Global safety outcomes of mesenchymal stem-cell infusions: A meta-analysis of 1,200 patients. Stem Cell Reviews and Reports, 20(4), 501–514.*